International Biological and Biomedical Journal(IBBJ)
A. Scope of the Journal:
The International Biological and Biomedical Journal (IBBJ) is a peer-reviewed, quarterly publication of 1001 Medical Association, Amol, Iran. The journal covers all cellular & molecular biology and medicine disciplines such as the genetic basis of disease, biomarker discovery in diagnosis and treatment, genomics and proteomics, bioinformatics, computer applications in human biology, stem cells and tissue engineering, medical biotechnology, nanomedicine, cellular processes related to growth, death and survival, clinical biochemistry, molecular & cellular immunology, molecular and cellular aspects of infectious disease and cancer research.
The following types of papers are considered for publication: original research works, reviews, mini- reviews, case reports, short communications and letters to the editor in the above mentioned fields.
B. Manuscript Format:
Manuscripts should be prepared in the Vancouver Style and must be submitted in Word (.doc) format. Only articles in English are considered for publication. Do not embed tables or figures. Please include the Title page, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Acknowledgement and References in a single file. Manuscripts containing original material are accepted for consideration with the understanding that neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted for publication elsewhere.
This should include:
- A brief, specific title
- All authors listed by first name, last name, and their affiliations, and current addresses.
- The corresponding author’s name and contact information (address, email, fax, tel)
The summary should be no more than 250 words and consist of four sections labeled Background, Methods, Results and Conclusions. They should briefly describe the problem being addressed in the study, how the study was performed, the salient results and what conclusions can be made from the results. Three to eight keywords should be added to the end of the Summary. Please use Index Medicus subject headings ( http://www.nlm.nih.gov/mesh/MBrowser.html ).
The manuscript should be typed, double-spaced, with 2.5 cm margins. This implies a word limit of appr. 3500 words in the main text of the paper Use footnotes only in tables and figures, not to elaborate on the article text. To verify drug names (use generic names only, adding the brand name afterward in parentheses if relevant). Abbreviations and/or acronyms should be spelled out in full and abbreviated in parentheses on first use in the text.
All measures should be reported in SI units followed, in the text, by traditional units in parentheses. For general guidance on the International System of Units and some useful conversion factors, see 'The SI for the Health Professions' (WHO, 1977). There are two exceptions: blood pressure should be expressed in mm Hg and haemoglobin as g/dl.
Words to be abbreviated should be spelt out in full the first time they appear in the text with the abbreviations in brackets. Thereafter, the abbreviation should be used.
References should be numbered consecutively according to the order in which they are cited in the text. A reference cited only in a table or figure is numbered within the sequence established by the first mention of that table or figure in the text.
References must be current. Use of references more than 10 years old is discouraged unless they are classic or unique works.
Authors must verify all references. The reference list should follow the text of the manuscript. Follow the Vancover Style for reference formatting and punctuation.
In the reference list, abbreviate names of journals according to MEDLINE/Index Medicus. For four or more authors, list the first three names followed by "et al." Please note the following examples for format and punctuation:
1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin 2008;58(2):71-96.
2. Eifel PJ, Levenback C. American Cancer Society Atlas of Clinical Oncology: Cancer of the Female Lower Genital Tract. Hamilton, Ontario: BC Decker, Inc.; 2001.
Chapter in a book:
3. Park BH, Vogelstein B. Tumor-Suppressor Genes, In: Kufe DW, Pollock RE, Weichselbaum RR, et al. (eds). Cancer Medicine. 6th ed. Hamilton, Ontario: BC Decker, Inc.; 2003:87-106.
4. Health on the Net Foundation. Health on the Net Foundation code of conduct (HONcode) for medical and health Web sites. Available at: http://www.hon.ch / HONcode / Conduct. html. Accessed August 26, 2003.
Tables must be created using the table tool in Word (.doc). Each table must be in a separate file, and the files should be named by table # (i.e., table 1, table 2, etc.). Footnotes can be included below the table. They should have a brief descriptive title placed at the top. Number the tables consecutively in the order in which they are cited in the text. Do not use bulleted lists in tables. Do not embed tables in the manuscript text.
Figures and Illustrations:
Authors are encouraged to submit their figure files in color . Illustrations should be numbered consecutively to the order in which they are cited in the text, given suitable legends. Original drawings may be submitted although high quality glossy photographs are preferable. They should be kept separate from the text. Do not embed figures in the manuscript text. The same data should not be presented in tables, figures and text, simultaneously.
(line art): Electronic Formatting:
Each figure should be saved in a separate file.
Text/labeling within figures should be in 9 pt. Arial font to ensure readability in print. IBBJ reserves the right to resize and/or crop photographs to fit the journal’s format where appropriate.
C. General Considerations:
1. Peer review process
Manuscripts that adhere to submission guidelines are initially reviewed by the Editor of IBBJ . Manuscripts qualified for peer review are sent to at leastt three expert reviewers. The corresponding author will receive all editorial communications regarding the status of the manuscript, revisions, and reviews. All revisions and the dissemination of the reviewers’ comments and other manuscript information to co-authors are the corresponding author’s responsibility. The manuscript has to be submitted online at www.ibbj.org.
After receiving the final acceptance, authors can not claim the withdrawal of their manuscript.
2. Cover letter
Each article should be accompanied by a cover letter, signed and dated by corresponding author specifying the following statement: “The manuscript has been seen and approved by all authors and is not under active consideration for publication, has not been accepted for publication, nor has it been published in another journal in full or part" (except in abstract form). This letter should be scan and upload via prerequeisit section in manuscript submission form. Cover letter sample file
3. Conflicts of interest:
Authors should disclose, at the time of submission, information on financial conflicts of interest or other interests that may influence the manuscript. Authors should declare sources of funding for the work undertaken.
4. Ethical considerations:
Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors and include the name of the appropriate institutional review board that approved the project. It is necessary to indicate in the text that the maintenance and care of experimental animals complies with the current laws of the country in which they were performed.
All listed authors must sign the copyright transfer agreement. No article will be published without a copyright transfer agreement signed by all the listed authors. The signed copyright transfer agreement should be scanned and submitted online.
After receiving the final acceptance, the authors cannot claim the withdrawal of their manuscript.
All open access articles published in IBBJ are distributed under the terms of the Creative Commons Attribution CC BY.
6. Corresponding author responsibilities:
• Only one corresponding author is allowed per manuscript.
The corresponding author is the point of contact for the Editorial Office and Publisher. He or she is responsible for:
• Collecting signed copyright transfer agreements and CME disclosure forms from all authors and submitting these to the Editorial Office with the manuscript.
• Sharing the reviewers’ comments with the other authors and ensuring the requested revisions are made or clearly disputed before resubmitting the manuscript.
• Page proofs. The publisher will e-mail page proofs to the corresponding author. It is up to the corresponding author to share these proofs with the other authors. The corresponding author is responsible for incorporating all the corrections made by the authors and returning the proofs to the publisher within 48 hours.
• Reviewing the IBBJ cover. The corresponding author of the article featured on the cover of an issue of IBBJ will receive PDF files of cover designs from the Editorial Office. He or she may share these designs with the other authors, but the corresponding author is responsible for ensuring any figure/tables/illustrations taken from the article (or supplied specifically for use on the cover) have been reproduced clearly and accurately, and for verifying the accuracy of their use for the Editorial Office.
7. Page charges:
The journal doesn't have any submission and article processing charges (APCs).
The Final Checklist
The authors must ensure that before submitting the manuscript for publication, they have taken care of the following:
1. Title page should contain title, name of the author/coauthors, designation & institutions they are affiliated with and mailing address for future correspondence, email address, Phone & Fax number.
2. Text of article and References prepared as stated in Manuscript Format.
3. Tables should be typed on separate pages.
4. Covering Letter